Access to information delays affect all government records, not just vaccine data, and the government has committed to reviewing the entire system to improve transparency. Extensive post-market surveillance confirms vaccines' strong safety profile, with serious adverse events exceptionally rare. The access regime's problems stem from operational challenges across all departments — requiring comprehensive reform rather than singling out specific topics.